Pirtobrutinib Activity Against C481S-Mediated Resistance

John details that pirtobrutinib inhibits wild-type BTK and C481S mutants, explaining how non-covalent binding overcomes common resistance.

Play episode from 15:26

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!